1-4 of 4
Charles S. Hemenway, MD, PhD
Close
Sort by
Journal Articles

Structural and Functional Studies Of The Intrinsically Disordered Protein AF9 In MLL-AF9 Leukemia

Aravinda Kuntimaddi, Alyson Lokken, Shubin Zhang, Jeremy Thorpe, Benjamin Leach, PhD, Bhavna Lumba, PhD, Charles S. Hemenway, MD, PhD, Mazhar Adli, PhD, Nancy J. Zeleznik-Le, PhD, John H. Bushweller, PhD
Journal: Blood
Blood (2013) 122 (21): 3762.
https://doi.org/10.1182/blood.V122.21.3762.3762
Published: 2013
Journal Articles

The Role of the Intrinsically Disordered and Multifunctional AF9 C-Terminal Domain in MLL-AF9 Leukemia,

John H. Bushweller, PhD, Benjamin Leach, Ming-jin Chang, Bhavna Lumba, Tomasz Cierpicki, PhD, Nancy J. Zeleznik-Le, PhD, Charles S. Hemenway, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3464.
https://doi.org/10.1182/blood.V118.21.3464.3464
Published: 2011
Journal Articles

Strategies for Therapeutic Peptide Delivery by Mesenchymal Stem Cells

Xian-Yang Zhang, PhD, Lisa To, BA, Jakob Reiser, PhD, Charles S. Hemenway, MD, PhD, Michel W Sadelain, MD, PhD, Vincent F. La Russa, PhD
Journal: Blood
Blood (2008) 112 (11): 863.
https://doi.org/10.1182/blood.V112.11.863.863
Published: 2008
Journal Articles

Enhancing the Therapeutic Potential of an Anti-Leukemic Peptide.

Christine M. Palermo, PhD, William C. Wimley, PhD, Charles S. Hemenway, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 245.
https://doi.org/10.1182/blood.V106.11.245.245
Published: 2005